News
June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health ...
The Supreme Court upheld the constitutionality of an Affordable Care Act provision requiring insurance coverage of certain preventive services without cost-sharing. Many healthcare leaders applauded ...
Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech ...
How Emerging Hospital Bed Technology Can Help Patients Rest Easier And Recover Faster - MedCity News
Despite their necessity, beds and surfaces do not always receive proportional attention and innovation — even as the risks associated with prolonged bed rest remain a key priority for caregivers.
Cigna launched these tools to make the customer experience as seamless as possible, according to Chris DeRosa, executive vice president of business improvement and innovation at The Cigna Group ...
Over the past couple of years, ambient scribes have earned widespread adoption among health systems. While there's excitement around other categories like AI agents, no other AI use case has ...
AHIP executives discussed the impact the proposed budget bill could have on Medicaid and the individual market.
AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs ...
The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses is the latest blow to national defense, former health ...
California’s SB553, the nation’s first comprehensive and multi-industry workplace violence prevention law, has been in effect for almost a year. Many other states are following suit with their ...
In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.
Trump said this policy change is needed because high drug prices in the U.S. subsidize low drug prices in foreign markets, an imbalance that amounts to other countries getting a “free ride ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results